- Home
- UBCP vs MURA Comparison
UBCP vs MURA Comparison
Compare UBCP & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBCP
- MURA
- Stock Information
- Founded
- UBCP 1902
- MURA 2013
- Country
- UBCP United States
- MURA Ireland
- Employees
- UBCP N/A
- MURA N/A
- Industry
- UBCP Major Banks
- MURA
- Sector
- UBCP Finance
- MURA
- Exchange
- UBCP Nasdaq
- MURA Nasdaq
- Market Cap
- UBCP 78.8M
- MURA 45.8M
- IPO Year
- UBCP N/A
- MURA N/A
- Fundamental
- Price
- UBCP $14.01
- MURA $2.49
- Analyst Decision
- UBCP
- MURA Strong Buy
- Analyst Count
- UBCP 0
- MURA 3
- Target Price
- UBCP N/A
- MURA $12.00
- AVG Volume (30 Days)
- UBCP 7.0K
- MURA 93.6K
- Earning Date
- UBCP 08-06-2025
- MURA 08-12-2025
- Dividend Yield
- UBCP 6.42%
- MURA N/A
- EPS Growth
- UBCP N/A
- MURA N/A
- EPS
- UBCP 1.24
- MURA N/A
- Revenue
- UBCP $29,412,000.00
- MURA N/A
- Revenue This Year
- UBCP N/A
- MURA N/A
- Revenue Next Year
- UBCP $5.59
- MURA N/A
- P/E Ratio
- UBCP $11.49
- MURA N/A
- Revenue Growth
- UBCP N/A
- MURA N/A
- 52 Week Low
- UBCP $11.40
- MURA $0.95
- 52 Week High
- UBCP $15.64
- MURA $4.74
- Technical
- Relative Strength Index (RSI)
- UBCP 49.64
- MURA 50.31
- Support Level
- UBCP $13.92
- MURA $2.42
- Resistance Level
- UBCP $14.75
- MURA $2.58
- Average True Range (ATR)
- UBCP 0.65
- MURA 0.09
- MACD
- UBCP -0.06
- MURA 0.01
- Stochastic Oscillator
- UBCP 30.04
- MURA 46.08
About UBCP United Bancorp Inc.
United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.